Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision-Reference-Cited by-同舟云学术

Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision

Published:2022-08-31 Issue:3 Volume:11 Page:96-104
ISSN:2186-361X
Container-title:Intractable & Rare Diseases Research
language:en
Short-container-title:IRDR

Author:

Lu Yanqin¹,Gao Qingxia²,Ren Xiuzhi³,Li Junfeng⁴,Yang Dan⁴,Zhang Zijian⁴,Han Jinxiang⁴

Affiliation:

1. Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, Shandong, China.

2. Neck-Shoulder and Lumbocrural Pain Hospital, Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

3. Orthopedic Surgery, The People's Hospital of Wuqing District, Tianjin, China.

4. Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/irdr/11/3/11_2022.01093/_pdf

Reference53 articles.

1. 1. Melnikova I. Rare diseases and orphan drugs. Nature Reviews Drug Discovery. 2012; 11:267-268.

2. 2. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur J Hum Genet. 2020; 28:165-173.

3. 3. He J, Tang M, Zhang X, Chen D, Kang Q, Yang Y, Hu J, Jin C, Song P. Incidence and prevalence of 121 rare diseases in China: Current status and challenges. Intractable Rare Dis Res. 2019; 8:89-97.

4. 4. Shourick J, Wack M, Jannot AS. Assessing rare diseases prevalence using literature quantification. Orphanet J Rare Dis. 2021; 16:139.

5. 5. He J, Kang Q, Hu J, Song P, Jin C. China has officially released its first national list of rare diseases. Intractable Rare Dis Res. 2018; 7:145-147.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of Organic Aciduria Diseases in Tunisia: A 35-year Retrospective Study;Saudi Journal of Medicine & Medical Sciences;2024

2. Gender differences in the burden of multiple sclerosis in China from 1990 to 2019 and its 25‐year projection: An analysis of the Global Burden of Diseases Study;Health Science Reports;2023-11-29

3. Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features;Frontiers in Immunology;2023-11-16

4. Systematic literature review of the epidemiology of glycogen storage disease type 1a;Journal of Pediatric Endocrinology and Metabolism;2023-08-25

5. Barriers to prophylactic treatment among patients with haemophilia A in Shandong Province, China: a qualitative study;Orphanet Journal of Rare Diseases;2023-08-03